Form 4: Dolby CEO Yeaman Reports Significant Equity Transactions

Dolby Laboratories CEO Kevin Yeaman reported a series of equity transactions, including new stock and option grants, vesting of previous awards, and sales of shares under a 10b5-1 trading plan.

Summary

• CEO Kevin Yeaman received new grants of 65,968 Restricted Stock Units (RSUs) and 32,984 Performance-Based Restricted Stock Units (PSUs) on December 15, 2025.
• He also received a grant of 145,252 Employee Stock Options on December 15, 2025, with an exercise price of $66.62 and an expiration date of December 15, 2035.
• 17,633 Performance-Based Restricted Stock Units (PSUs) from a prior grant (target 27,273 shares) vested on December 15, 2025, after achieving 64.65% of the performance criteria for the period ending December 10, 2025. The remaining 9,640 PSUs were cancelled.
• A total of 34,035 shares were withheld by the Issuer on December 15 and 16, 2025, to cover withholding taxes related to the vesting of RSUs and PSUs, at prices of $67.54 and $66.62 respectively.
• Yeaman sold a total of 33,517 Class A Common Stock shares between December 16 and 17, 2025, under a 10b5-1 trading plan adopted on February 28, 2025, at weighted average prices ranging from $66.6404 to $67.2351.
• Following these transactions, Yeaman's direct beneficial ownership of Class A Common Stock (including unvested RSUs) is 98,377 shares, with additional indirect ownership via a trust and a son.

Sentiment

Score: 7

Explanation: The filing indicates routine executive compensation activities, including significant new equity grants that align the CEO's interests with long-term company performance. While there were share sales, they were pre-planned under a 10b5-1 plan, which is a neutral event. The partial achievement of a prior performance award is also a neutral to slightly positive indicator of past performance.

Positives

• CEO Kevin Yeaman received significant new equity grants, including 65,968 RSUs, 32,984 PSUs (target), and 145,252 employee stock options, aligning his interests with long-term shareholder value.
• A prior PSU award successfully vested 17,633 shares, indicating achievement of performance criteria at 64.65% of the target for the performance period.

Negatives

• CEO Kevin Yeaman sold 33,517 shares of Class A Common Stock over three days, which could be perceived as a reduction in direct exposure, although these sales were pre-planned under a 10b5-1 plan.
• 9,640 PSUs from a previous grant were cancelled due to not meeting the full performance criteria, indicating that the company did not achieve 100% of the target performance for that period.

Risks

• The vesting of the new 32,984 Performance-Based Restricted Stock Units (PSUs) is contingent on achieving specific performance criteria, including annualized total shareholder return compared to the S&P Mid Cap 400 Index over a three-year performance period (December 15, 2025, to December 12, 2028), meaning the actual number of shares received could range from 0% to 200% of the target award.
• The value of the newly granted employee stock options and RSUs is subject to the future market price of Dolby Laboratories' Class A Common Stock.

Future Outlook

The CEO's future compensation is tied to the company's performance, with new Performance-Based Restricted Stock Units (PSUs) vesting based on annualized total shareholder return relative to the S&P Mid Cap 400 Index over a three-year period ending December 12, 2028. Additionally, new Restricted Stock Units (RSUs) and Employee Stock Options will vest over the next four years, aligning executive incentives with long-term company growth.

Industry Context

This Form 4 filing details routine executive compensation and trading activities for the CEO of Dolby Laboratories, a company known for audio and imaging technologies. The use of performance-based equity awards, tied to relative total shareholder return against a benchmark like the S&P Mid Cap 400 Index, is a common practice in the technology and media industry to incentivize executive performance and align with shareholder interests.

Comparison to Industry Standards

• The use of 10b5-1 trading plans for executive share sales is a standard practice across publicly traded companies, providing an affirmative defense against insider trading allegations by pre-scheduling transactions.
• Granting performance-based restricted stock units (PSUs) tied to relative total shareholder return (TSR) against an industry benchmark like the S&P Mid Cap 400 Index is a common and well-regarded executive compensation structure in the technology sector, similar to practices at companies like NVIDIA, Adobe, or Microsoft, which aim to align executive incentives with long-term shareholder value creation.
• The vesting schedule for RSUs (1/4 annually) and stock options (1/4 on first anniversary, then monthly over 36 months) is typical for executive equity awards in the tech industry, designed to promote retention and long-term commitment.

Corporate Governance

Related Party Transactions

• Shares were issued to and are now held by the Kevin and Rachel Yeaman Family Trust dated May 14, 2009, in connection with the vesting of restricted stock units and performance-based restricted stock units.
• Beneficial ownership includes shares held indirectly by a son.

Stakeholder Impact

• Shareholders: The new equity grants align the CEO's long-term interests with shareholder value creation, as a significant portion of his compensation is tied to stock performance and total shareholder return. The sales under a 10b5-1 plan are pre-scheduled and generally not seen as a negative signal.
• Employees: The grants of RSUs, PSUs, and stock options are part of a broader compensation strategy that may also extend to other key employees, potentially boosting morale and retention.

Next Steps

• Vesting of 65,968 Restricted Stock Units (RSUs) in 1/4 increments annually starting December 15, 2025.
• Vesting of 145,252 Employee Stock Options, with 1/4 vesting on December 15, 2026, and the remainder vesting monthly over the subsequent 36 months.
• Evaluation of performance criteria for the 32,984 Performance-Based Restricted Stock Units (PSUs) over the three-year period ending December 12, 2028, with actual vesting occurring after certification by the Compensation Committee.

Key Dates

Keywords

Dolby Laboratories, DLB, Kevin Yeaman, SEC Form 4, Insider Trading, Stock Options, Restricted Stock Units, Performance-Based Stock Units, 10b5-1 Plan, Executive Compensation, Share Sales